This inconsistency may be attributed to two factors: first, the microarrays of ovarian cancer used for IHC comprised various subtypes of ovarian cancer tissues, and STMN1 expression levels differed significantly among these subtypes (Figure H, I). Here, STMN1 is linked to ovarian cancer.